Furthermore, the loss of wild-type (wt) p53 function in clinical cancer specimens of prostate, melanoma and ovary has been revealed to be manifested by the lower level of THBS1 expression and enhanced tumor dissemination [36]. This evidence concerns the gene THBS1 and cancer.